![IJMS | Free Full-Text | The Association between Apolipoprotein B, Cardiovascular Risk Factors and Subclinical Atherosclerosis—Findings from the SEPHAR National Registry on Hypertension in Romania IJMS | Free Full-Text | The Association between Apolipoprotein B, Cardiovascular Risk Factors and Subclinical Atherosclerosis—Findings from the SEPHAR National Registry on Hypertension in Romania](https://pub.mdpi-res.com/ijms/ijms-24-02813/article_deploy/html/images/ijms-24-02813-g001.png?1675257804)
IJMS | Free Full-Text | The Association between Apolipoprotein B, Cardiovascular Risk Factors and Subclinical Atherosclerosis—Findings from the SEPHAR National Registry on Hypertension in Romania
![Multiomic Analysis and CRISPR Perturbation Screens Identify Endothelial Cell Programs and Novel Therapeutic Targets for Coronary Artery Disease | Arteriosclerosis, Thrombosis, and Vascular Biology Multiomic Analysis and CRISPR Perturbation Screens Identify Endothelial Cell Programs and Novel Therapeutic Targets for Coronary Artery Disease | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/84fcc214-2ad4-4fb4-8f85-f2d75ef1e371/atvbaha.123.318328.fig01.jpg)
Multiomic Analysis and CRISPR Perturbation Screens Identify Endothelial Cell Programs and Novel Therapeutic Targets for Coronary Artery Disease | Arteriosclerosis, Thrombosis, and Vascular Biology
![JoX | Free Full-Text | Rates of Divergent Pharmacogenes in a Psychiatric Cohort of Inpatients with Depression—Arguments for Preemptive Testing JoX | Free Full-Text | Rates of Divergent Pharmacogenes in a Psychiatric Cohort of Inpatients with Depression—Arguments for Preemptive Testing](https://www.mdpi.com/jox/jox-12-00022/article_deploy/html/images/jox-12-00022-g003.png)
JoX | Free Full-Text | Rates of Divergent Pharmacogenes in a Psychiatric Cohort of Inpatients with Depression—Arguments for Preemptive Testing
![Efficacy and safety of moderate-intensity statin with ezetimibe combination therapy in patients after percutaneous coronary intervention: a post-hoc analysis of the RACING trial - eClinicalMedicine Efficacy and safety of moderate-intensity statin with ezetimibe combination therapy in patients after percutaneous coronary intervention: a post-hoc analysis of the RACING trial - eClinicalMedicine](https://www.thelancet.com/cms/attachment/f740f4b6-375a-4219-930e-08d8cbf517fe/gr1.jpg)
Efficacy and safety of moderate-intensity statin with ezetimibe combination therapy in patients after percutaneous coronary intervention: a post-hoc analysis of the RACING trial - eClinicalMedicine
![Cells | Free Full-Text | Extracellular Release of Citrullinated Vimentin Directly Acts on Osteoclasts to Promote Bone Resorption in a Mouse Model of Periodontitis Cells | Free Full-Text | Extracellular Release of Citrullinated Vimentin Directly Acts on Osteoclasts to Promote Bone Resorption in a Mouse Model of Periodontitis](https://www.mdpi.com/cells/cells-12-01109/article_deploy/html/images/cells-12-01109-g001.png)
Cells | Free Full-Text | Extracellular Release of Citrullinated Vimentin Directly Acts on Osteoclasts to Promote Bone Resorption in a Mouse Model of Periodontitis
![The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030 - The Lancet The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030 - The Lancet](https://www.thelancet.com/cms/attachment/93e50fe6-93f2-493d-89ed-34c5a9281bf6/gr1_lrg.jpg)
The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030 - The Lancet
![Efficacy and safety of moderate-intensity statin with ezetimibe combination therapy in patients after percutaneous coronary intervention: a post-hoc analysis of the RACING trial - eClinicalMedicine Efficacy and safety of moderate-intensity statin with ezetimibe combination therapy in patients after percutaneous coronary intervention: a post-hoc analysis of the RACING trial - eClinicalMedicine](https://www.thelancet.com/cms/attachment/bd424c6c-1798-411d-a4d6-9b6b276176d0/gr3.jpg)
Efficacy and safety of moderate-intensity statin with ezetimibe combination therapy in patients after percutaneous coronary intervention: a post-hoc analysis of the RACING trial - eClinicalMedicine
![Apolipoprotein A1 Protects Against Necrotic Core Development in Atherosclerotic Plaques: PDZK1-Dependent High-Density Lipoprotein Suppression of Necroptosis in Macrophages | Arteriosclerosis, Thrombosis, and Vascular Biology Apolipoprotein A1 Protects Against Necrotic Core Development in Atherosclerotic Plaques: PDZK1-Dependent High-Density Lipoprotein Suppression of Necroptosis in Macrophages | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/a77f6c1b-8169-41b6-b70b-ae4033f37f96/atvbaha.122.318062.fig06.jpg)
Apolipoprotein A1 Protects Against Necrotic Core Development in Atherosclerotic Plaques: PDZK1-Dependent High-Density Lipoprotein Suppression of Necroptosis in Macrophages | Arteriosclerosis, Thrombosis, and Vascular Biology
![9 Ozone | Emergency and Continuous Exposure Guidance Levels for Selected Submarine Contaminants: Volume 2 |The National Academies Press 9 Ozone | Emergency and Continuous Exposure Guidance Levels for Selected Submarine Contaminants: Volume 2 |The National Academies Press](https://nap.nationalacademies.org/books/12032/gif/184.gif)